Bollard Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $892K | Hold |
361,136
| – | – | 0.02% | 123 |
|
|
2025
Q1 | $719K | Hold |
361,136
| – | – | 0.02% | 120 |
|
|
2024
Q4 | $1.06M | Hold |
361,136
| – | – | 0.03% | 104 |
|
|
2024
Q3 | $1.4M | Hold |
361,136
| – | – | 0.04% | 107 |
|
|
2024
Q2 | $1.86M | Hold |
361,136
| – | – | 0.05% | 85 |
|
|
2024
Q1 | $2.53M | Hold |
361,136
| – | – | 0.08% | 74 |
|
|
2023
Q4 | $3.2M | Buy |
+361,136
| New | +$3.2M | 0.11% | 63 |
|